Regulation of Mammary Stem/Progenitor Cells by PTEN/Akt/β-Catenin Signaling
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Recent evidence suggests that many malignancies, including breast cancer, are driven by a cellular subcomponent that displays stem cell-like properties. The protein phosphatase and tensin homolog (PTEN) is inactivated in a wide range of human cancers, an alteration that is associated with a poor prognosis. Because PTEN has been reported to play a role in the maintenance of embryonic and tissue-specific stem cells, we investigated the role of the PTEN/Akt pathway in the regulation of normal and malignant mammary stem/progenitor cell populations. We demonstrate that activation of this pathway, via PTEN knockdown, enriches for normal and malignant human mammary stem/progenitor cells in vitro and in vivo. Knockdown of PTEN in normal human mammary epithelial cells enriches for the stem/progenitor cell compartment, generating atypical hyperplastic lesions in humanized NOD/SCID mice. Akt-driven stem/progenitor cell enrichment is mediated by activation of the Wnt/beta-catenin pathway through the phosphorylation of GSK3-beta. In contrast to chemotherapy, the Akt inhibitor perifosine is able to target the tumorigenic cell population in breast tumor xenografts. These studies demonstrate an important role for the PTEN/PI3-K/Akt/beta-catenin pathway in the regulation of normal and malignant stem/progenitor cell populations and suggest that agents that inhibit this pathway are able to effectively target tumorigenic breast cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Knockdown of PTEN in normal mammary epithelial cells implanted into humanized mouse fat pads resulted in disorganized, hyperplastic lesions (44).”
From Mislocalization of the Cell Polarity Protein Scribble Promotes Mammary Tumorigenesis and Is Associated with Basal Breast Cancer (2014) · cites this paper as [44]
In the citing paper
“These outgrowths displayed increased basal markers (smooth muscle actin, CK5, CK6) and decreased luminal markers (estrogen receptor, CK18), similar to our findings with mislocalization of SCRIB.”
From Mislocalization of the Cell Polarity Protein Scribble Promotes Mammary Tumorigenesis and Is Associated with Basal Breast Cancer (2014) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012 · cited 8×
“Mammary tissue from reduction mammoplasties was dissociated as previously described [19].”
BackgroundMethodInfluentialSelf-citationA collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J.-P., Tong, F., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,188 · cited 1×
“screened 38 breast cancer cell lines including MCF7 for various pathways and found that MCF7 cells displayed significantly low levels of the PI3/Akt activation when compared with other cell lines [52].”
BackgroundmTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561 · cited 1×
“loop [43–46].”
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M. J., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,406 · cited 2×
“Mammosphere cultures were grown in a serum-free mammary epithelium basal medium as previously described [18].”
BackgroundMethodSelf-citationSato, N., Meijer, L., Skaltsounis, L., Greengard, P., & Brivanlou, A. H. (2004) · Nature Medicine · doi:10.1038/nm979 · Cited by 2,109 · cited 1×
“To examine the role of Wnt/b-catenin signaling, we used the GSK3-b inhibitor 6-bromoindirubin-39-oxime (Bio), which has been shown to be able to maintain pluripotency of human and mouse embryonic stem cells through activation of bcatenin signaling [30].”
MethodNagata, Y., Lan, K.-H., Zhou, X., Tan, M., Esteva, F. J., Sahin, A. A., Klos, K. S., Li, P., Monia, B. P., Nguyen, N. T., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.022 · Cited by 1,858 · cited 2×
“therapeutic agents and relapse following initial treatment [7,8].”
BackgroundInfluentialIntrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
Li, X., Lewis, M. T., Huang, J., Gutierrez, C., Osborne, C. K., Wu, M.-F., Hilsenbeck, S. G., Pavlick, A., Zhang, X., Chamness, G. C., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn123 · Cited by 1,794 · cited 1×
“Recent evidence utilizing in vitro systems [56], animal models [13], and clinical trials have suggested that breast cancer stem cells are relatively resistant to both radiation and chemotherapy [57].”
BackgroundBerns, K., Horlings, H. M., Hennessy, B. T., Madiredjo, M., Hijmans, E. M., Beelen, K., Linn, S. C., Gonzalez-Angulo, A. M., Stemke-Hale, K., Hauptmann, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.030 · Cited by 1,627
Purification and unique properties of mammary epithelial stem cells
Stingl, J., Eirew, P., Ricketson, I., Shackleton, M., Vaillant, F., Choi, D., Li, H. I., & Eaves, C. J. (2006) · Nature · doi:10.1038/nature04496 · Cited by 1,559 · cited 1×
“Furthermore, recent studies have shown that mammary stem cells are not contained within the SP population [47].”
BackgroundPten is essential for embryonic development and tumour suppression
Cristofano, A. D., Pesce, B., Cordon-Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,516 · cited 2×
“heterozygous mice developing tumors in several organs including the breast [5,34].”
Background
Cited by
Items 101–200 of 532
Dubrovska, A., Hartung, A., Bouchez, L. C., Walker, J. R., Reddy, V. A., Cho, C. Y., & Schultz, P. G. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.105 · Cited by 119
“PI3K, CXCR4 and GSK3 pathways are known to be involved in the regulation of progenitor population and drug sensitivity in breast cancers (Zhou et al, 2007; Hwang-Verslues et al, 2009; Korkaya et al, 2009; Huang et al, 2010).”
BackgroundStem Cells in the Human BreastPreprint
Petersen, O. W., & Polyák, K. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003160 · Cited by 119
“(3,4,5)-trisphosphate (PIP3); this antagonizes the growth-promoting PI3-K/Akt pathway and loss of PTEN correlates with poor prognosis in breast cancer (Korkaya et al. 2009).”
BackgroundMcCubrey, J. A., Abrams, S. L., Fitzgerald, T. L., Cocco, L., Martelli, A. M., Montalto, G., Cervello, M., Scalisi, A., Candido, S., Libra, M., et al. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.09.016 · Cited by 126
Schöning, J. P., Monteiro, M., & Gu, W. (2017) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12693 · Cited by 115
Debeb, B. G., Lacerda, L., Xu, W., Larson, R. A., Solley, T. N., Atkinson, R. L., Sulman, E. P., Ueno, N. T., Krishnamurthy, S., Reuben, J. M., et al. (2012) · Stem Cells · doi:10.1002/stem.1219 · Cited by 126
Li, B., Lü, Y., Yu, L., Han, X., Wang, H., Mao, J., Shen, J., Tang, J., Tang, J., Li, C., et al. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.08.014 · Cited by 120
Unraveling the journey of cancer stem cells from origin to metastasis
Nimmakayala, R. K., Batra, S. K., & Ponnusamy, M. P. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.10.006 · Cited by 123
Yuan, H., Guo, H., Luan, X., He, M., Li, F., Burnett, J., Truchan, N. A., & Sun, D. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01221 · Cited by 120
Revisiting the role of Wnt/β-catenin signaling in prostate cancer
Schneider, J. A., & Logan, S. K. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.008 · Cited by 121
“Growing evidence shows that Wnt/β-catenin signaling is highly active in CSCs, and may have a role in prostate stem cell self-renewal (Bisson and Prowse, 2009; Korkaya et al., 2009).”
BackgroundIt’s a Lipid’s World: Bioactive Lipid Metabolism and Signaling in Neural Stem Cell Differentiation
Bieberich, E. (2012) · Neurochemical Research · doi:10.1007/s11064-011-0698-5 · Cited by 112
“PTEN catalyzes the hydrolysis of PIP3 to PIP2, which leads to inactivation of the Akt/PKB cell signaling pathway [75–77].”
West, N. R., Murray, J. I., & Watson, P. H. (2013) · Oncogene · doi:10.1038/onc.2013.105 · Cited by 124
Kaushik, N. K., Kaushik, N., Yoo, K. C., Uddin, M. N., Kim, J. S., Lee, S., & Choi, E. H. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.02.014 · Cited by 116
Leptin–cytokine crosstalk in breast cancer
Newman, G. W., & Gonzalez-Perez, R. R. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.03.025 · Cited by 119
“Leptin is also involved in the regulation of factors associated to BCSC, i.e., HER2 (Korkaya et al., 2008; Korkaya and Wicha, 2009), Akt (Korkaya et al., 2009) as well as transcriptional factors, such as STAT3 (Zhou et al., 2007), NF-κB (Pratt et al., 2009).”
Liu, J. C., Voisin, V., Wang, S., Wang, D., Jones, R. A., Datti, A., Uehling, D., Al‐awar, R., Egan, S. E., Bader, G. D., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404402 · Cited by 110
“Dysregulation of the PI3K pathway induces AKT/PKB, leading to increased cell motility, proliferation and survival, as well as increased protein translation via mTOR.”
BackgroundHelm, J. S., & Rudel, R. A. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02752-z · Cited by 119
Signaling pathways in HPV‐associated cancers and therapeutic implications
Chen, J. (2015) · Reviews in Medical Virology · doi:10.1002/rmv.1823 · Cited by 118
“Activation of the PI3K/Akt pathway decreases the sensitivity of CSCs to chemotherapeutic drugs [335,337].”
BackgroundChang, W.-W., Lin, R.-J., Yu, J., Chang, W.-Y., Fu, C.-H., Lai, A. C.-Y., Yu, J.-C., & Yu, A. L. (2013) · Breast Cancer Research · doi:10.1186/bcr3423 · Cited by 108
“Korkaya and colleagues demonstrated that phosphatase and tensin homolog knockdown increased phosphorylation of Akt, leading to enriched normal and malignant mammary stem/progenitor cells, and that this Akt-driven process was mediated by the Wnt/b-catenin pathway [46].”
Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation
Lee, T. K., Castilho, A., Cheung, V. C. H., Tang, K. H., Ma, S., & Ng, I. O. (2010) · Hepatology · doi:10.1002/hep.24000 · Cited by 114
“Our result is consistent with recent findings that showed the role of PTEN in the enrichment of stem cells in breast and brain tumors.(30,34) The increased number of hepatospheres formed, and the percentage of cells needed to form secondary spheres also demonstrated the role of PTEN in the self-renewal process.”
ResultThe Cancer Stem Cell Hypothesis: A Guide to Potential Molecular Targets
Allegra, A., Alonci, A., Penna, G., Innao, V., Gerace, D. G., Rotondo, F., & Musolino, C. (2014) · Cancer Investigation · doi:10.3109/07357907.2014.958231 · Cited by 115
Role of the tumor microenvironment in the pathogenesis of gastric carcinoma
Chung, H. W., & Lim, J.-B. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i7.1667 · Cited by 111
Antiangiogenic Therapies: Going beyond Their Limits
Moserle, L., Jiménez-Valerio, G., & Casanovas, O. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0199 · Cited by 102
Breast Cancer Stem Cells: Current Advances and Clinical Implications
Luo, M., Clouthier, S. G., Deol, Y. S., Liu, S., Nagrath, S., Azizi, E., & Wicha, M. S. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2519-3_1 · Cited by 112
Self-citationNakanishi, T., Chumsri, S., Khakpour, N., Brodie, A., Leyland-Jones, B., Hamburger, A. W., Ross, D. D., & Burger, A. M. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605553 · Cited by 104
“…Cancer Research UK C lin ic a l S tu d ie s Emerging evidence suggests that the HER2/AKT pathway regulates T-ICs in BC by activating the Wnt pathway (Korkaya et al, 2009); however, a precise mechanism of the manner in which Wnt signalling contributes to the BC T-IC phenotype requires further…”
BackgroundTransglutaminase is a tumor cell and cancer stem cell survival factor
Eckert, R. L., Fisher, M. L., Grun, D., Adhikary, G., Xu, W., & Kerr, C. L. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22375 · Cited by 106
Chemotherapy-Resistant Metastatic Breast Cancer
Marquette, C., & Nabell, L. M. (2012) · Current Treatment Options in Oncology · doi:10.1007/s11864-012-0184-6 · Cited by 112
Piggott, L., Omidvar, N., Pérez, S. M., Eberl, M., & Clarkson, R. W. (2011) · Breast Cancer Research · doi:10.1186/bcr2945 · Cited by 97
“Furthermore, it has been suggested that breast cancer stem cells may selectively express HER2 [59,45]) and that inhibition of this pathway could have beneficial consequences for breast cancer patients with both HER2-positive and HER2-negative disease [47,48].”
BackgroundMethodInfluentialA Breast Cancer Stem Cell-Selective, Mammospheres-Potent Osmium(VI) Nitrido Complex
Suntharalingam, K., Wei, L., Johnstone, T. C., Bruno, P. M., Zheng, Y., Hemann, M. T., & Lippard, S. J. (2014) · Journal of the American Chemical Society · doi:10.1021/ja508808v · Cited by 101
Role of microRNAs in the Regulation of Breast Cancer Stem Cells
Liu, S., Clouthier, S. G., & Wicha, M. S. (2012) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-012-9242-8 · Cited by 101
“These studies [9–11] have demonstrated the relative resistance of BCSC to chemotherapy and radiation therapy.”
BackgroundSelf-citationLim, S., Becker, A., Zimmer, A., Lu, J., Buettner, R., & Kirfel, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066558 · Cited by 90
Role of miR-148a in Hepatitis B Associated Hepatocellular Carcinoma
Yuan, K., Lian, Z., Sun, B. S., Clayton, M. M., Ng, I. O., & Feitelson, M. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035331 · Cited by 100
“However, siPTEN enhanced Akt and b-catenin expression (data not shown), as previously published [30].”
BackgroundSignaling pathways in the regulation of cancer stem cells and associated targeted therapy
Wang, M., & Wu, M. (2022) · MedComm · doi:10.1002/mco2.176 · Cited by 108
Zhang, L., Valdez, J. M., Zhang, B., Wei, L., Chang, J., & Xin, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018271 · Cited by 95
“epithelial stem cells using a mammosphere assay [41].”
MethodSchulenburg, A., Blatt, K., Cerny‐Reiterer, S., Sadovnik, I., Herrmann, H., Marian, B., Grunt, T. W., Zielinski, C. C., & Valent, P. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0113-9 · Cited by 98
Dastmalchi, N., Feizi, M. A. H., Khojasteh, S. M. B., Baradaran, B., & Safaralizadeh, R. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118239 · Cited by 95
Wu, C., Hong, B.-H., Ho, C., & Yen, G. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b00002 · Cited by 94
Kim, G., Ouzounova, M., Quraishi, A. A., Davis, A., Tawakkol, N., Clouthier, S. G., Malik, F. A., Paulson, A. K., D'Angelo, R. C., Korkaya, S., et al. (2014) · Oncogene · doi:10.1038/onc.2014.4 · Cited by 98
Self-citationBarradas, A. M. C., & Terstappen, L. W. M. M. (2013) · Cancers · doi:10.3390/cancers5041619 · Cited by 100
Tomao, F., Papa, A., Rossi, L., Strudel, M., Vici, P., Lo Russo, G., & Tomao, S. (2013) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-32-48 · Cited by 92
“The SC pool is also tightly regulated by signaling pathways from the microenvironment of the SC niche, and several of these pathways, including Hedgehog and Wnt, have been implicated in carcinogenesis [49,50].”
BackgroundMa, L., Zhang, G., Miao, X., Deng, X., Wu, Y., Liu, Y., Jin, Z., Li, X., Liu, Q., Sun, D., et al. (2013) · FEBS Journal · doi:10.1111/febs.12226 · Cited by 94
Xu, C. S., Xie, D., Yu, S., Yang, X.-J., He, L.-R., Yang, H. J., Ping, Y., Wang, B., Yang, L., Xu, S.-L., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4403 · Cited by 92
Li, B., Lü, Y., Wang, H., Han, X., Mao, J., Li, J., Yu, L., Wang, B., Fan, S., Yu, X., et al. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.01.045 · Cited by 97
RetractedSteelman, L. S., Navolanic, P. M., Chappell, W. H., Abrams, S. L., Wong, E. W. T., Martelli, A. M., Cocco, L., Stivala, F., Libra, M., Nicoletti, F., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.17.17119 · Cited by 92
Littlepage, L. E., Adler, A. S., Kouros‐Mehr, H., Huang, G., Chou, J., Krig, S. R., Griffith, O. L., Korkola, J. E., Qu, K., Lawson, D. A., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0093 · Cited by 88
Signaling in colon cancer stem cells
Roy, S., & Majumdar, A. P. N. (2012) · Journal of Molecular Signaling · doi:10.1186/1750-2187-7-11 · Cited by 92
“tion of epithelial stem cell self renewal [14,15].”
BackgroundMetformin Selectively Targets Tumor-Initiating Cells in ErbB2-Overexpressing Breast Cancer Models
Zhu, P. H., Davis, M. B., Blackwelder, A. J., Bachman, N., Liu, B., Edgerton, S. M., Williams, L. L., Thor, A. D., & Yang, X. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0181 · Cited by 87
“In context with the report that ErbB2–regulated mammary stem/progenitor cell population is a driving force of related tumorigenesis and invasion (15), and the regulation of PTEN/AKT/b-catenin signaling is vital in regulating mammary stem/progenitor cells (42), downregulation of RTK-activated PI3K/Akt, MAPK/Erk, mTOR/…”
BackgroundDeterminants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells
Pavlopoulou, A., Oktay, Y., Vougas, K. N., Louka, M. A., Vorgias, C. E., & Georgakilas, A. G. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.018 · Cited by 93
Cancer Stem Cell-Like Phenotype and Survival Are Coordinately Regulated by Akt/FoxO/Bim Pathway
Gargini, R., Cerliani, J. P., Escoll, M., Antón, I. M., & Wandosell, F. G. (2014) · Stem Cells · doi:10.1002/stem.1904 · Cited by 88
Activation of the AKT/cyclin D1/Cdk4 survival signaling pathway in radioresistant cancer stem cells
Shimura, T., Noma, N., Oikawa, T., Ochiai, Y., Kakuda, S., Kuwahara, Y., Takai, Y., Takahashi, A., & Fukumoto, M. (2012) · Oncogenesis · doi:10.1038/oncsis.2012.12 · Cited by 86
PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting
Ciuffreda, L., Falcone, I., Incani, U. C., Curatolo, A. D., Conciatori, F., Matteoni, S., Vari, S., Vaccaro, V., Cognetti, F., & Milella, M. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.07.002 · Cited by 88
Deng, T., Liang, A., Liang, S., Ma, X., Lu, X., Duan, A., Pang, C., Hua, G., Liu, S., Campanile, G., et al. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00036 · Cited by 92
“(2002) reported that TCL1B is one member of the TCL1 protooncogene family that could enhance the phosphorylation and activation of AKT1 and AKT2, which is involved in the PI3KAkt signaling pathway related to mammary gland development and lactation (Korkaya et al., 2009).”
BackgroundMethylome analysis reveals Jak-STAT pathway deregulation in putative breast cancer stem cells
Hernández‐Vargas, H., Ouzounova, M., Calvez‐Kelm, F. L., Lambert, M.-P., McKay‐Chopin, S., Tavtigian, S. V., Puisieux, A., Matar, C., & Herceg, Z. (2011) · Epigenetics · doi:10.4161/epi.6.4.14515 · Cited by 88
Economopoulou, P., Kaklamani, V., & Siziopikou, K. P. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0163 · Cited by 87
“Furthermore, treatment with Akt inhibitor perifosine leads to a decrease in number of CSCs and tumor growth in breast cancer xenografts [84] and sensitizes CSCs to radiation in p53 null mice [85].”
BackgroundThe role of hypoxia-inducible factor-1 alpha in multidrug-resistant breast cancer
Yong, L., Tang, S., Yu, H., Zhang, H., Zhang, Y., Wan, Y., & Cai, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.964934 · Cited by 91
“HIF-1a promoted stem cell enrichment, in part, through the Akt/b-catenin pathway, which was reported to be a key regulator of CSC self-renewal in breast cancer, because HIF1a increased levels of both phospho-Akt and phospho-S552 -b-catenin in SUM159 cells, and b-catenin was inactivated (not phosphorylated) when HIF-1a…”
BackgroundAdams, A., Warner, K. A., Pearson, A. T., Zhang, Z., Kim, H. S., Mochizuki, D., Basura, G. J., Helman, J. I., Mantesso, A., CASTILHO, R. M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5782 · Cited by 81
Self-citationLacerda, L., Pusztai, L., & Woodward, W. A. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.08.001 · Cited by 81
Gupta, V. K., Bhinge, K. N., Hosain, S. B., Xiong, K., Gu, X., Shi, R., Ho, M., Khoo, K., Li, S., Li, Y., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.396390 · Cited by 79
ABC transporters in CSCs membranes as a novel target for treating tumor relapse
Zinzi, L., Contino, M., Cantore, M., Capparelli, E., Leopoldo, M., & Colabufo, N. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00163 · Cited by 81
FoxOs, Wnts and oxidative stress-induced bone loss: new players in the periodontitis arena?
Galli, C., Passeri, G., & Macaluso, G. M. (2011) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2011.01354.x · Cited by 84
Smart, C. E., Morrison, B. J., Saunus, J. M., Vargas, A. C., Keith, P., Reid, L., Wockner, L. F., Askarian-Amiri, M., Sarkar, D., Simpson, P. T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064388 · Cited by 92
“It is possible that previous reports of positive correlations between stem cell marker frequency, sphere formation, radiationand chemo-resistance and in vivo tumourigenicity may have lead to some overgenerous definitions of CSCs and the suitability of the sphere-assay for functional investigation [3,4,6,18].”
Curcumin and cancer stem cells: curcumin has asymmetrical effects on cancer and normal stem cells.
Sordillo, P. P., & Helson, L. (2015) · PubMed · Cited by 88
NF-kappaΒ-inducing kinase regulates stem cell phenotype in breast cancer
Vázquez-Santillán, K., Meléndez-Zajgla, J., Jimenez-Hernandez, L. E., Gaytán-Cervantes, J., Muñoz-Galindo, L., Piña‐Sánchez, P., Martinez‐Ruíz, G. U., Torres, J., García‐López, P., González-Torres, C., et al. (2016) · Scientific Reports · doi:10.1038/srep37340 · Cited by 79
How pregnancy at early age protects against breast cancer
Meier‐Abt, F., & Bentires‐Alj, M. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.11.002 · Cited by 82
Deng, H., Zhang, X., Wang, Μ., Zheng, H., Liú, L., & Wang, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088034 · Cited by 75
Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies
Amengual-Cladera, E., Morla-Barcelo, P. M., Morán-Costoya, A., Valle, A., Pons, D. G., Sastre‐Serra, J., Roca, P., & Nadal‐Serrano, M. (2024) · Biology · doi:10.3390/biology13050302 · Cited by 86
Gigantol Suppresses Cancer Stem Cell-Like Phenotypes in Lung Cancer Cells
Bhummaphan, N., & Pithi Chanvorachote, B. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/836564 · Cited by 71
PI3K in stemness regulation: from development to cancer
Madsen, R. R. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190778 · Cited by 70
Zhang, J.-N., Huang, K., Shi, Z., Zou, J., Wang, Y., Jia, Z., Zhang, A., Han, L., Yue, X., Liu, N., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor034 · Cited by 72
Salivary gland cancer stem cells
Adams, A., Warner, K. A., & Nor, J. E. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2013.05.013 · Cited by 68
Li, Y., & Zhang, T. (2013) · Future Oncology · doi:10.2217/fon.13.108 · Cited by 68
“(2013) 9(8) 1098 future science group However, currently available chemotherapeutic drugs and radiotherapy lack the ability to effectively kill CSCs [19,20,22,23], although they can shrink tumors [20].”
BackgroundInfluentialSmit, L., Berns, K., Spence, K., Ryder, W. D. J., Zeps, N., Madiredjo, M., Beijersbergen, R. L., Bernards, R., & Clarke, R. B. (2015) · Oncotarget · doi:10.18632/oncotarget.6354 · Cited by 71
“The identified shRNAs target genes involved in signaling pathways known to regulate breast cancer stem cells, including WNT (SFRP1), CD44 (FKBPL), and the PI3K/AKT (FOXO3A) signaling pathways [14, 19, 34-36].”
BackgroundStem Cells in Normal Development and Cancer
D'Angelo, R. C., & Wicha, M. S. (2010) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385071-3.00006-x · Cited by 70
Self-citationHe, K., Xu, T., Xu, Y., Ring, A., Kahn, M., & Goldkorn, A. (2013) · International Journal of Cancer · doi:10.1002/ijc.28341 · Cited by 73
“PI3K=Akt signaling is mediated downstream by GSK3b and b-catenin, which have been shown to impact mammary stem cell properties in mouse models and in human cancer cells.(25,29) GSK3b normally phosphorylates b-catenin at Ser33, Ser37 and Thr41, thereby promoting its degradation and diminishing its nuclear transcription…”
BackgroundResultSignaling events mediated by α3β1 integrin are essential for mammary tumorigenesis
Cagnet, S., Faraldo, M. M., Kreft, M., Sonnenberg, A., Raymond, K., & Glukhova, M. A. (2013) · Oncogene · doi:10.1038/onc.2013.391 · Cited by 65
Cancer stem cell theory: therapeutic implications for nanomedicine
Huang, J., Wang, X., Wu, & Wang (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s38641 · Cited by 76
MicroRNA100 Inhibits Self-Renewal of Breast Cancer Stem–like Cells and Breast Tumor Development
Deng, L., Li, S., Bai, S., Chen, J., He, X., Martin-Trevino, R., Chen, S., Li, X., Meng, X., Yu, B., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3710 · Cited by 65
“Our previous studies showed that the Wnt/β-catenin pathway is an important regulator of BCSC self-renewal (44).”
BackgroundSelf-citationWhole Grain Consumption for the Prevention and Treatment of Breast Cancer
Xie, M., Liu, J., Tsao, R., Wang, Z., Sun, B., & Wang, J. (2019) · Nutrients · doi:10.3390/nu11081769 · Cited by 65
Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells
Alam, M., Rajabi, H. N., Ahmad, R., Jin, C., & Kufe, D. W. (2014) · Oncotarget · doi:10.18632/oncotarget.1848 · Cited by 69
“HER2 drives stem cell-like activity by AKTβ catenin signaling [47, 48] and through an interaction between HER2 and CXCR1/2 [18].”
BackgroundTargeting stem cells in the realm of drug-resistant breast cancer
Dey, P., Rathod, M., & De, A. (2019) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s189224 · Cited by 73
Developmental pathways in breast cancer and breast tumor-initiating cells: Therapeutic implications
Izrailit, J., & Reedijk, M. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.11.028 · Cited by 64
The molecular mechanisms underlying the therapeutic resistance of cancer stem cells
Kim, J.-K., Jeon, H.-Y., & Kim, H. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0531-1 · Cited by 64
“Self-renewal and differentiation of CSCs are mainly reg- ulated by various developmental signaling pathways including Wnt, Notch, and Hedgehog signaling (Korkaya et al. 2009; Ward et al. 2009; Agarwal and Matsui 2010; Hoey et al. 2009; Harrison et al. 2010).”
BackgroundFani, S., Kamalıdehghan, B., Lo, K. M., Nigjeh, S. E., Yeap, S. K., Dehghan, F., Soori, R., Abdulla, M. A., Chow, K. M., Ali, H. M., et al. (2016) · Scientific Reports · doi:10.1038/srep38992 · Cited by 65
The Next Generation of Anticancer Metallopharmaceuticals: Cancer Stem Cell‐Active Inorganics
Laws, K., & Suntharalingam, K. (2018) · ChemBioChem · doi:10.1002/cbic.201800358 · Cited by 62
Wnt Signaling in Mammary Glands: Plastic Cell Fates and Combinatorial Signaling
Alexander, C. M., Goel, S., Fakhraldeen, S. A., & Kim, S. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008037 · Cited by 63
“Data also suggest that activation of Akt signaling may be a component of Wnt ligand-mediated oncogenesis, and this outcome may make ectopic Wnt signaling difficult to recognize by a genetic signature (Korkaya et al. 2009; Zhang et al. 2010b).”
BackgroundImplications of stemness-related signaling pathways in breast cancer response to therapy
Angeloni, V., Tiberio, P., Appierto, V., & Daidone, M. G. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.08.004 · Cited by 62
Fitz, C. D. V., Jensen, K. C., Nitta, R. T., Shain, A. H., Giacomini, C. P., & Wong, A. J. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2656 · Cited by 61
Therapeutic Effectiveness of Anticancer Phytochemicals on Cancer Stem Cells
Oh, J., Hlatky, L., Jeong, Y., & Kim, D.-H. (2016) · Toxins · doi:10.3390/toxins8070199 · Cited by 61
“Several studies have also demonstrated that sulforaphane can downregulate Akt signaling in various solid cancers [84,85] and breast CSCs [86].”
BackgroundPires, B. R. B., de Amorim, Í. S. S., Souza, L. D. E., Rodrigues, J. A., & Mencalha, A. L. (2016) · Anticancer Research · doi:10.21873/anticanres.11151 · Cited by 65
mTOR inhibitors counteract tamoxifen-induced activation of breast cancer stem cells
Karthik, G.-M., Ma, R., Lövrot, J., Kis, L. L., Lindh, C., Blomquist, L., Fredriksson, I., Bergh, J. C. S., & Hartman, J. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.017 · Cited by 66
Novel anticancer activity of phloroglucinol against breast cancer stem-like cells
Kim, R.-K., Uddin, N., Hyun, J., Kim, C., Suh, Y., & Lee, S. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.03.026 · Cited by 61
Crocetinic acid inhibits hedgehog signaling to inhibit pancreatic cancer stem cells
Rangarajan, P., Subramaniam, D., Paul, S., Kwatra, D., Palaniyandi, K., Islam, S., Harihar, S., Ramalingam, S., Gutheil, W. G., Putty, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4871 · Cited by 58
“A hallmark feature of cancer stem cells is the formation of large, floating spheres, termed spheroids that can be serially passaged [33].”
BackgroundWon, H., Lee, J., Shin, D., Park, J., Nam, J., Kim, H., & Kong, G. (2012) · The FASEB Journal · doi:10.1096/fj.12-209247 · Cited by 58
Morales, G. A., Garlich, J. R., Su, J., Peng, X., Newblom, J., Weber, K. T., & Durden, D. L. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301522m · Cited by 59
Myc is required for β-catenin-mediated mammary stem cell amplification and tumorigenesis
Moumen, M., Chiche, A., Decraene, C., Petit, V., Gandarillas, A., Deugnier, M., Glukhova, M. A., & Faraldo, M. M. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-132 · Cited by 58
“In human mammary epithelial cells, activation of the Wnt/β-catenin pathway after PTEN knockdown has been shown to induce the amplification of the stem/progenitor compartment [20].”
BackgroundNatural Products That Target Cancer Stem Cells.
Moselhy, J., Srinivasan, S., Ankem, M. K., & Damodaran, C. (2015) · PubMed · Cited by 68
CD44 targets Wnt/β-catenin pathway to mediate the proliferation of K562 cells
Chang, G., Zhang, H., Wang, J., Zhang, Y., Xu, H. Z., Wang, C., Zhang, H., Ma, L., Li, Q., & Pang, T. (2013) · Cancer Cell International · doi:10.1186/1475-2867-13-117 · Cited by 57
Ho, A. T. V., Hayashi, S., Bröhl, D., Aurade, F., Rattenbach, R., & Relaix, F. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.06.019 · Cited by 56
Han, X., Wei, B., Fang, J., Shi, Z., Zhang, F., Zhang, H., Lan, T., Hui-qiong, L., & Wei, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073341 · Cited by 56
“Recent studies have reported the pivotal role of Wnt/b-catenin signaling pathway in the self-renewal of epithelial stem cells [30,31].”
BackgroundNicotine increases cancer stem cell population in MCF-7 cells
Hirata, N., Sekino, Y., & Kanda, Y. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.134 · Cited by 56
Gong, J., Kelekar, G., Shen, J., Shen, J., Kaur, S., & Mita, M. M. (2016) · Targeted Oncology · doi:10.1007/s11523-016-0423-z · Cited by 60
Moreira, M. P., Braga, L. D. C., Cassali, G. D., & Silva, L. M. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.01.018 · Cited by 61
Metadata
- Authors
- Korkaya, H., Paulson, A., Charafe-Jauffret, E., Ginestier, C., Brown, M., Dutcher, J., Clouthier, S. G., & Wicha, M. S.
- Affiliations
- University of Michigan (US)
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-06-02
- Volume
- 7
- Issue
- 6
- Pages
- e1000121
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC2683567
- OpenAlex
- W2009094422
- Cited by
- 523
- References
- 58
- Citations by year
- 2025: 8 · 2024: 11 · 2023: 16 · 2022: 21 · 2021: 21 · 2020: 23 · 2019: 21 · 2018: 21 · 2017: 23 · 2016: 39 · 2015: 59 · 2014: 42 · 2013: 65 · 2012: 64
- FWCI
- 25.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- University of Michigan
- A. Alfred Taubman Medical Research Institute
- National Institutes of Health (CA46592)
- School of Medicine, Stanford University
- National Cancer Institute (CA101860, 5P30 CA 46592, R01CA129765, CA129765, R01CA101860, P30CA046592)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Keywords
- mammary stem/progenitor cells, PTEN, Akt signaling, Wnt/β-catenin signaling, breast cancer, perifosine, PI3K/Akt signaling, atypical hyperplasia, breast tumor xenografts, cancer stem cells
- MeSH terms
- Animals, Breast, Breast Neoplasms, Female, Gene Expression Regulation, Humans, Mammary Glands, Animal, Stem Cells, Neoplastic Stem Cells, Signal Transduction, Mice, SCID, Mice, Inbred NOD, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, PTEN Phosphohydrolase, beta Catenin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.